Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BOM:524520'
s ROE % Range Over the Past 10 Years
Min: 13.92 Med: 24.86 Max: 31.61
Current: 25.17
During the past 13 years, KMC Speciality Hospitals (India)'s highest ROE % was 31.61%. The lowest was 13.92%. And the median was 24.86%.
BOM:524520's ROE % is ranked better than 89.21% of 621
companies
in the Healthcare Providers & Services industry
Industry Median: 6.01
vs BOM:524520: 25.17
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
KMC Speciality Hospitals (India) ROE % Related Terms
KMC Speciality Hospitals (India) ROE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, KMC Speciality Hospitals (India)'s ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KMC Speciality Hospitals (India) ROE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, KMC Speciality Hospitals (India)'s ROE % distribution charts can be found below:
* The bar in red indicates where KMC Speciality Hospitals (India)'s ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
KMC Speciality Hospitals (India) (BOM:524520) has a ROE % of 27.81% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on KMC Speciality Hospitals (India) and its competitors. This is 12% above median its historical median of 24.86. Over the past decade, KMC Speciality Hospitals (India)'s ROE % has ranged from 13.92 to 31.61. According to the industry distribution chart, KMC Speciality Hospitals (India) ranks #67 out of 621 companies in the Healthcare Providers & Services industry, placing it in the top 10.8%.
Is KMC Speciality Hospitals (India)'s ROE % too high?
KMC Speciality Hospitals (India)'s current ROE % of 27.81% is 12% above median its 10-year median of 24.86. Over the past 10 years, this metric has ranged from a low of 13.92 to a high of 31.61. The Healthcare Providers & Services industry median ROE % is 6.01. KMC Speciality Hospitals (India)'s value of 27.81% is 362.7% above this industry median. Based on the distribution chart, KMC Speciality Hospitals (India) ranks #67 out of 621 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, KMC Speciality Hospitals (India) has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does KMC Speciality Hospitals (India)'s ROE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, KMC Speciality Hospitals (India) ranks #67 out of 621 companies for ROE %. This places KMC Speciality Hospitals (India) in the top 11% of its industry — outperforming the majority of peers. The industry median ROE % is 6.01. KMC Speciality Hospitals (India)'s value of 27.81% is 362.7% above this benchmark. Historically, KMC Speciality Hospitals (India)'s own ROE % has ranged from 13.92 to 31.61 over the past decade. While the company's 10-year median is 24.86 vs. the industry median of 6.01, KMC Speciality Hospitals (India) has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 6.01, based on 621 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. KMC Speciality Hospitals (India)'s current ROE % of 27.81% is 362.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on KMC Speciality Hospitals (India) and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 6.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KMC Speciality Hospitals (India)'s current ROE % is 27.81%, which is 12% above median its own 10-year median of 24.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KMC Speciality Hospitals (India) stock overvalued right now?
Based on GuruFocus' analysis, KMC Speciality Hospitals (India) (BOM:524520) is currently considered Fairly Valued. The stock's GF Value™ is ₹126.93, compared to a current price of ₹127.60 — trading 0.5% above its estimated fair value. The current ROE % is 27.81%, which is 12% above median its 10-year median of 24.86 and 362.7% above the Healthcare Providers & Services industry median of 6.01. KMC Speciality Hospitals (India)'s overall GF Score™ is 84/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For KMC Speciality Hospitals (India) (BOM:524520), the current ROE % is 27.81% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KMC Speciality Hospitals (India) (BOM:524520) Overvalued in 2026?
Based on GuruFocus' analysis, KMC Speciality Hospitals (India) stock appears to be overvalued.
The current stock price of ₹127.60 is trading 0.5% above its estimated GF Value™ of ₹126.93.
GuruFocus considers KMC Speciality Hospitals (India) to be Fairly Valued.
Key valuation signals for BOM:524520:
ROE %: 27.81% (12% above median its 10-year median of 24.86)
GF Value™: ₹126.93 vs. price of ₹127.60 (0.5% above fair value)
Industry Position: 362.7% above the Healthcare Providers & Services median (#67 of 621)
No single metric tells the full story. See the BOM:524520 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KMC Speciality Hospitals (India) Ltd is a healthcare services and pharmacy company. It is engaged in the business of rendering medical and healthcare services. The company offers varieties of departments and care centers such as cardiac science, neurology and neuroscience, orthopedics, spine surgery, gastroenterology, liver diseases, and transplantation and vascular surgery. The company's sole operating segment is Medical and Healthcare Services. The company operates solely in India.
84GF Score
Get the complete analysis for BOM:524520
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524520 has been successfully added to your 
